Carelabs케어랩스
263700 · KOSDAQ · ₩263700 · 케어랩스
₩1,979▼ ₩41 (2.03%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩17B | ₩21B | ₩15B | ₩21B | ₩23B | ₩23B | ₩22B | ₩19B |
| Operating income | −₩723M | ₩675M | −₩5.7B | −₩587M | ₩2.6B | ₩841M | −₩3.3B | −₩746M |
| Net income | −₩1.1B | −₩196M | ₩21B | −₩403M | −₩26B | ₩25B | −₩17B | ₩1.9B |
| Net income to shareholders | −₩1.4B | −₩608M | ₩20B | −₩403M | −₩26B | ₩25B | −₩12B | −₩3B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩99B | ₩102B | ₩107B | ₩105B | ₩108B | ₩107B | ₩143B | ₩163B |
| Current assets | ₩40B | ₩44B | ₩50B | ₩55B | ₩66B | ₩65B | ₩99B | ₩103B |
| Cash and equivalents | ₩20B | ₩24B | ₩40B | ₩42B | ₩53B | ₩50B | ₩31B | ₩32B |
| Total liabilities | ₩26B | ₩28B | ₩33B | ₩27B | ₩29B | ₩27B | ₩88B | ₩97B |
| Current liabilities | ₩24B | ₩26B | ₩30B | ₩24B | ₩26B | ₩24B | ₩84B | ₩68B |
| Borrowings | — | — | — | — | — | — | ₩44B | ₩46B |
| Total equity | ₩73B | ₩74B | ₩75B | ₩78B | ₩79B | ₩80B | ₩55B | ₩67B |
| Shareholders' equity | ₩67B | ₩68B | ₩68B | ₩72B | ₩73B | ₩74B | ₩48B | ₩60B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩88M | −₩4.8B | ₩1.6B | −₩2.1B | ₩2.4B | −₩883M | −₩14B | ₩12B |
| Capital spending | ₩1.8B | ₩575M | — | — | — | — | — | — |
| Free cash flow | −₩1.8B | −₩5.4B | ₩1.6B | −₩2.1B | ₩2.4B | −₩883M | −₩14B | ₩12B |
| Dividends paid | — | — | ₩24M | ₩0 | ₩0 | ₩490M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Carelabs / 케어랩스 / 263700 / KRX:263700
Source: KRX statistical information